Tauns Laboratories (TYO:197A) has withdrawn its application to shift to the Tokyo Stock Exchange's Prime Market, citing delays in the review process and the need to revise submitted materials, according to a Monday filing on the Tokyo Stock Exchange.
The company had submitted the application using the fiscal year ended June 2024 as its reference period, but now expects the Tokyo bourse will not approve it before its upcoming shareholder meeting in September.
Tauns said it still aims to pursue a move to the Prime Market and will reassess the timing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.